Skip to content
Screener

Establishment Labs ESTA Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
IAR
Integra LifeSciencesIART
-$22.39M-5.7%
Artivion logo
ArtivionAORT
$21.55M+36.6%
Globus Medical logo
Globus MedicalGMED
-$53.21M+77.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Establishment Labs’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001688757-26-000041
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Repayments on short term notes payable for insurance premium financing(1,170)
Proceeds from stock option exercises1,00879
Tax payments related to shares withheld upon vesting of restricted stock(702)(282)
Net cash used in financing activities(864)(203)
Effect of exchange rate changes on cash and cash equivalents(337)1,095
Net decrease in cash and cash equivalents(7,471)(21,169)
Cash and cash equivalents at beginning of period75,57290,347
Cash at end of period$68,101$69,178

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's net change in cash?
Establishment Labs (ESTA) reported net change in cash of -$7.47M in Q1 2026.
How has Establishment Labs's net change in cash changed year-over-year?
Establishment Labs's net change in cash increased by 64.7% year-over-year, from -$21.17M to -$7.47M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Establishment Labs's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude